Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
قم بشراء هذا الكتاب الإلكتروني واحصل على كتاب آخر مجانًا!
شكل EPUB ● صفحات 268 ● ISBN 9781315355900 ● محرر Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● الناشر CRC Press ● نشرت 2016 ● للتحميل 3 مرات ● دقة EUR ● هوية شخصية 5021283 ● حماية النسخ Adobe DRM
يتطلب قارئ الكتاب الاليكتروني قادرة DRM